AVERA MARSHALL REGIONAL MEDICAL CTR — History
CCN 241359 | 3-year financial timeline | COVID resilience: 26/100
🛡️ Public data only — no PHI permitted on this instance.
$115M
Latest Revenue (FY2022)
-5.4%
Revenue CAGR (3yr)
-17.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $129M | $127M | $115M | -9.4% | -5.4% |
| Operating Expenses | $129M | $136M | $135M | -1.1% | +2.1% |
| Operating Margin | -0.3% | -7.1% | -17.0% | -138.1% | +0.0% |
| Net Income | $-0M | $-9M | $-20M | -115.7% | +0.0% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 4,121 | 3,846 | 3,323 | -13.6% | -10.2% |
| Medicare Day % | 37% | 29% | 28% | -5.7% | -14.0% |
| Medicaid Day % | 3% | 4% | 3% | -17.5% | +7.0% |
COVID Impact & Recovery
Resilience Score: 26/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -10.6% ($129M → $115M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-5.4%
This Hospital
+7.6%
State Avg
Latest Margin
-17.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $108M | -25.4% |
| FY2024 (proj) | $102M | -33.7% |
| FY2025 (proj) | $95M | -42.1% |